Archived: 7th Winter Conference
on Medicinal & Bioorganic Chemistry
February 26th - March 1st 2006
Sheraton Sand Key Resort, Florida
Agenda
Sunday, February 26th 2006
Medicinal Chemistry for Bio-Defense
Program Chair: Wayne Brouillette, University of Alabama – Birmingham / Lester A. Mitscher, University of Kansas
Good Bugs. What’s the Difference?
Novel Tyrosine Phosphatase Inhibitors for Treatment of Yersinia Infections
Riverside Smallpox as a Novel Drug Target
Where it has been and where might it go in the 21st Century
Monday, February 27th 2006
Recent Advances in Organic Chemistry Methodology
Program Chair: Albert Padwa, Emory University
Metals Methods, and Molecules
Biomimetic Synthesis via Polyepoxide Cyclizations
Genetic Screens and Selections for Small Molecules
Tailoring Biocatalysts for Enantioselective Synthesis
New Therapies for Treating Viral Diseases and Cancers
General Oral Papers I
Program Chair: John Dodd, Bristol-Meyers Squibb
Synthesis and Evaluation of Thioesterase Affinity Labels
Rationally Designed Antibiotics That Inhibit Siderophore Biosynthesis of Mycobacterium tuberculosis
Stereoselective Routes to Bioactive Heterocycles: An AminoAcid Chiral Template Approach
Furan-2-glmethylene-Azolidine-Diones as novel, potent and selective inhibitors of Phosphoinositide 3-Kinase g
Discovery of a potent, orally active Phenylalanine Derived Dipeptidyl Peptidase IV Inhibitor for the treatment of Type 2 Diabetes
Poster Session
Program Chair: Jack Hodges, Berry and Associates
Wednesday, March 1st 2006
Young Investigators in Organic Synthesis
Program Chair: Michael VanNieuwenhze, University of California - San Diego
Synthesis and Study of Cyclic Depsipeptides that Inhibit Bacterial Cell Wall Biosynthesis
Development of Photoactivated Glutamate Receptors and Other Studies in Total Synthesis
Synthetic Applications and Mechanistic Investigations of Directed C–H Bond Oxidation
Modulation of Bacterial Communication Pathways with Synthetic Ligands
Synthesis and Discovery of a Novel Multi-targeted Anti-angiogenic Kinase Inhibitor (MAK)
Media Sponsors
